Emily dives into the ins and outs of 23andMe, discussing their services and goals.

Emily Drabant Conley, Ph.D. joined 23andMe in 2010 and currently serves as research scientist and director of business development. She is responsible for building strategic partnerships with pharmaceutical and biotech companies, forging research collaborations, and overseeing project execution across a range of therapeutic areas.23andMe is the first and only genetic service available directly to you that includes reports that meet FDA standards.

For more information, check out:
More videos and livestreams: http://www.drapertv.com
Residential program: http://www.draperuniversity.com
Online Courses: http://www.courses.drapertv.com

Subscribe for more videos!

source